83 results on '"Schrappe, M"'
Search Results
2. FOS and FOSB are linked with CNS-infiltration and inferior prognosis in childhood T-cell acute lymphoblastic leukemia
3. Stratification and prognosis of IGH-DUX4 positive acute lymphoblastic leukemia in children
4. Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies
5. CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
6. Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome
7. Targeting CD38 in T-ALL using a novel Fc-engineered antibody
8. Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia
9. Prognostic Impact of Sex in Pediatric ALL in three consecutive ALL-BFM trials
10. Die another way: necroptosis as alternative route to cell death
11. Health services Research Faces New Challenges: Consequences for Definition and Concept
12. Versorgungsforschung vor neuen Herausforderungen: Konsequenzen für Definition und Konzept
13. TP53 single nucleotide variants (SNV) in patients developing second malignant neoplasms after treatment for childhood acute lymphoblastic leukemia
14. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial AIEOP-BFM ALL 95
15. Impact of the gene expression of natural killer cell receptors and their ligands for treatment response and prognosis in pediatric acute lymphoblastic leukemia
16. Ressourcenverknappung in der Medizin: Chance oder Risiko für die Patientensicherheit?
17. Gene expression analysis of NK cell receptors and their ligands in childhood acute lymphoblastic leukemia with involvement of the central nervous system
18. Prognostic relevance of the expression of genes associated with the P2RY8-CRLF2 fusion in acute lymphoblastic leukemia in childhood
19. Incidence and genetic characterization of childhood acute lymphoblastic leukemia with CRLF2 overexpression treated according to the AIEOP-BFM ALL 2009 protocol
20. A Case of Concordant Twins with Infant ALL and Discordant Clinical Outcome – Part II: highlights on an immunoescape phenotype as a potential mechanism of disease persistence
21. Entwicklung, Anwendung und Evaluation eines Konzeptes zur sicheren Patientenidentifikation im Krankenhaus – Wie kann der Wissenstransfer gelingen?
22. A Case of Concordant Twins with Infant ALL and Discordant Clinical Outcome – Part I: the genetic basis – identification of DSC2 as a gene with prognostic impact in infant MLL-rearranged ALL
23. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines
24. Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
25. Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
26. Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
27. Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
28. Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
29. Health services research: essential for allocation decisions - joint statement
30. Methods of Health Economic Evaluation for Health Services Research
31. Prof. Dr. Hansjörg Riehm, ein Leben für die Wissenschaft
32. Key Treatment Questions in Childhood Acute Lymphoblastic Leukemia: Results in 5 Consecutive Trials Performed by the ALL-BFM Study Group From 1981 to 2000
33. Lineage Classification of Childhood Acute Lymphoblastic Leukemia according to the EGIL Recommendations: Results of the ALL-BFM 2000 Trial
34. Prediction of Outcome by Early Response in Childhood Acute Lymphoblastic Leukemia
35. Editorial zum 80. Geburtstag von Prof. Riehm
36. Prediction of minimal residual disease in pediatric ALL: Evaluation of the predictive potential of the variables from the ALL-BFM 2000 trial
37. TGF-β signaling causes ALL quiescence
38. p38α/β inhibition prevents ALL proliferation in vivo
39. Identification of germline polymorphisms associated with clinical and toxicity phenotypes in childhood acute lymphoblastic leukemia
40. A mathematical approach to data evaluation with focus on prediction of minimal residual disease in pediatric ALL
41. Role of three childhood acute lymphoblastic leukemia-associated SNPs in a pediatric non-Hodgkin lymphoma cohort
42. Versorgungsforschung: unverzichtbar bei Allokationsentscheidungen – eine Stellungnahme
43. Varianz in der Epidemiologie unerwünschter Ereignisse: Methodik des Harvard Medical Practice Design
44. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
45. Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia
46. Versorgungsforschung: Konzept und Methodik
47. Patientensicherheitsindikatoren zur Arzneimitteltherapiesicherheit (AMTS-PSI): Internationaler Status, Übertragbarkeit und Validierung
48. Clinical Goals of Targeted Therapy in Childhood ALL
49. Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia - The I-BFM Approach
50. The Role of Activated NOTCH Signaling in Childhood T-ALL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.